Tag: COVID-19 vaccine
Vaxxas kickstarts needle-free COVID-19 vaccine clinical trial
Australian biotechnology company Vaxxas has begun the Phase I clinical trial of the first needle-free COVID-19 vaccine candidate.Â
Samsung Biologics to add end-to-end mRNA vaccine manufacturing capability to its portfolio of services
Contract development and manufacturing organisation (CDMO) Samsung Biologics has unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility...
Moderna to expand its manufacturing technology centre in US
COVID-19 vaccine maker Moderna will more than double production and lab space at its technology centre in Norwood, Massachusetts, US, through renovation of existing...
Australian scientists urge govt. to invest in domestic vaccine manufacturing capability
Scientists across Australia are urging the Government to develop the onshore manufacturing capability within the next twelve months.
In its 2021-22 Pre-Budget Submission, the Australian...
Government should invest in Australia’s vaccine manufacturing capability – The Greens
In light of recent AstraZeneca approval for use in Australia, the political party reiterated the need to further diversify jab availability in the country.
The...
Pfizer to speed up COVID-19 vaccine manufacture by half as production improves
US-based pharmaceutical company Pfizer will cut down manufacturing time of its COVID-19 vaccines by half – from 110 days to an average of 60...
GSK, CureVac team up to develop and manufacture vaccine against COVID-19 mutants
UK-based GlaxoSmithKline announced today that it has partnered with German pharmaceutical company CureVac to jointly develop next-generation mRNA vaccines for emerging COVID-19 variants.
The €150m...
UK to begin manufacturing 60 million doses of Valneva COVID-19 vaccine
As nations worldwide race to secure vaccine supplies, the UK gains an edge by greenlighting the manufacturing of a coronavirus vaccine candidate from France-headquartered...
Australia to purchase 51 million doses of COVID-19 vaccine from Novavax
American vaccine development company Novavax, Inc. has executed an Advance Purchase Agreement with the Commonwealth of Australia for 51 million doses of NVX-CoV2373, its...
Government seeks information on Aussie manufacturers that could produce COVID-19 vaccine locally
The Federal Government is putting a call out to local manufacturers as part of its strategy to produce a future vaccine and treatments for...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
